Share Twitter LinkedIn Facebook Email Brian Shuch, MD of the Yale School of Medicine discusses the Biomarker Analysis of MET Alterations and Papillary Subtype in S1500 at the 2017 Kidney Cancer Association symposium in Miami, FL.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read